EMEA-002747-PIP01-20-M01 - paediatric investigation plan

zilucoplan
PIPHuman

Key facts

Active Substance
zilucoplan
Therapeutic area
  • Neurology
  • Other
Decision number
P/0141/2023
PIP number
EMEA-002747-PIP01-20-M01
Pharmaceutical form(s)
  • Solution for injection in pre-filled syringe
  • Age appropriate dosage form for parenteral use
Condition(s) / indication(s)
Treatment of myasthenia gravis
Route(s) of administration
Subcutaneous use
Contact for public enquiries

UCB Pharma S.A.

Tel. + 353 14632371
E-mail: ucbcares.ie@ucb.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page